CN112336660A - Eye cream for relieving asthenopia and preparation method thereof - Google Patents
Eye cream for relieving asthenopia and preparation method thereof Download PDFInfo
- Publication number
- CN112336660A CN112336660A CN202011148300.6A CN202011148300A CN112336660A CN 112336660 A CN112336660 A CN 112336660A CN 202011148300 A CN202011148300 A CN 202011148300A CN 112336660 A CN112336660 A CN 112336660A
- Authority
- CN
- China
- Prior art keywords
- parts
- mixture
- eye cream
- antioxidant
- emollient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 42
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 10
- 239000000203 mixture Substances 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 24
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 22
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 20
- 125000003118 aryl group Chemical group 0.000 claims abstract description 19
- 239000002738 chelating agent Substances 0.000 claims abstract description 19
- 239000003974 emollient agent Substances 0.000 claims abstract description 19
- 239000003755 preservative agent Substances 0.000 claims abstract description 19
- 230000002335 preservative effect Effects 0.000 claims abstract description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003906 humectant Substances 0.000 claims abstract description 15
- 239000007957 coemulsifier Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 102000008186 Collagen Human genes 0.000 claims abstract description 8
- 108010035532 Collagen Proteins 0.000 claims abstract description 8
- 229920001436 collagen Polymers 0.000 claims abstract description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 6
- 229960003237 betaine Drugs 0.000 claims abstract description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960004063 propylene glycol Drugs 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims description 20
- 235000006708 antioxidants Nutrition 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims description 6
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 6
- 235000011201 Ginkgo Nutrition 0.000 claims description 6
- 244000194101 Ginkgo biloba Species 0.000 claims description 6
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 6
- 244000042664 Matricaria chamomilla Species 0.000 claims description 6
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 6
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims description 6
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 6
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 6
- 229940089161 ginsenoside Drugs 0.000 claims description 6
- 229930182494 ginsenoside Natural products 0.000 claims description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 6
- 239000002480 mineral oil Substances 0.000 claims description 6
- 235000010446 mineral oil Nutrition 0.000 claims description 6
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims description 6
- 229920002414 procyanidin Polymers 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- MNAHQWDCXOHBHK-UHFFFAOYSA-N 1-phenylpropane-1,1-diol Chemical compound CCC(O)(O)C1=CC=CC=C1 MNAHQWDCXOHBHK-UHFFFAOYSA-N 0.000 claims description 5
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 5
- 241001113925 Buddleja Species 0.000 claims description 5
- 244000201986 Cassia tora Species 0.000 claims description 5
- 235000014552 Cassia tora Nutrition 0.000 claims description 5
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 5
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 5
- 244000124209 Crocus sativus Species 0.000 claims description 5
- 235000015655 Crocus sativus Nutrition 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 5
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 5
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 5
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 5
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 5
- 102000019307 Sclerostin Human genes 0.000 claims description 5
- 108050006698 Sclerostin Proteins 0.000 claims description 5
- 244000044822 Simmondsia californica Species 0.000 claims description 5
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 5
- 235000013793 astaxanthin Nutrition 0.000 claims description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 5
- 229940022405 astaxanthin Drugs 0.000 claims description 5
- 239000001168 astaxanthin Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 235000021283 resveratrol Nutrition 0.000 claims description 5
- 229940016667 resveratrol Drugs 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 229940042585 tocopherol acetate Drugs 0.000 claims description 5
- 229940082500 cetostearyl alcohol Drugs 0.000 claims 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims 1
- 229940081733 cetearyl alcohol Drugs 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 230000009759 skin aging Effects 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 230000001934 delay Effects 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 41
- 206010040954 Skin wrinkling Diseases 0.000 description 13
- 235000011187 glycerol Nutrition 0.000 description 5
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 2
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Ophthalmology & Optometry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses eye cream for relieving asthenopia, which comprises the following components in parts by weight: 0.17-1.2 parts of humectant, 7.4-12.4 parts of emollient, 3.06-3.8 parts of antioxidant, 1.0-1.9 parts of soothing agent, 1.03-1.24 parts of co-emulsifier, 5.55-8.05 parts of skin conditioner, 0.68-1.6 parts of aromatic, 0.2 part of pH regulator, 1.4-1.6 parts of preservative, 0.4-0.5 part of chelating agent and the balance of solvent, 1.0 part of humectant, 8.4 parts of emollient, 3.6 parts of antioxidant, 1.5 parts of soothing agent, 1.2 parts of co-emulsifier, 6.0 parts of skin conditioner, 1.0 part of aromatic, 0.2 part of pH regulator, 1.5 parts of preservative, 0.45 part of chelating agent and 75.15 parts of water, wherein the humectant is any one or a mixture of two or more of propylene glycol, cetearyl alcohol and betaine. The invention effectively supplements collagen, reduces fishtail lines, enables the skin of a user to have long-term anti-oxidation effect, and delays skin aging.
Description
Technical Field
The invention belongs to the technical field of skin care products, and particularly relates to eye cream for relieving visual fatigue and a preparation method thereof.
Background
The eye cream is a skin-rejuvenating cosmetic which can relieve the problems of black eye, under-eye puffiness, fishtail lines, fat particles and the like caused by ultraviolet irradiation, long-time computer radiation, bad living habits and the like. The eye cream can relieve the problems so as to achieve the state of tight, fine and elastic eye skin.
With the progress of times, people pay more and more attention to skin care, so that various eye creams appear in the market, but the current eye creams are single in antioxidant substances and cannot provide long-term antioxidant effect, so that the skin is easy to age and has fishtail lines.
Disclosure of Invention
The invention aims to provide eye cream for relieving visual fatigue and a preparation method thereof, and aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: an eye cream for relieving asthenopia, which comprises the following components in parts by weight: 0.17-1.2 parts of humectant, 7.4-12.4 parts of emollient, 3.06-3.8 parts of antioxidant, 1.0-1.9 parts of soothing agent, 1.03-1.24 parts of co-emulsifier, 5.55-8.05 parts of skin conditioner, 0.68-1.6 parts of aromatic, 0.2 parts of pH regulator, 1.4-1.6 parts of preservative, 0.4-0.5 part of chelating agent and the balance of solvent.
Wherein, the skin care product comprises 1.0 part of humectant, 8.4 parts of emollient, 3.6 parts of antioxidant, 1.5 parts of soothing agent, 1.2 parts of co-emulsifier, 6.0 parts of skin conditioner, 1.0 part of aromatic, 0.2 part of pH regulator, 1.5 parts of preservative, 0.45 part of chelating agent and 75.15 parts of water.
Wherein the humectant is one or a mixture of two or more of propylene glycol, cetearyl alcohol and betaine;
the emollient is one or a mixture of two or more of cyclopentadimethylsiloxane, mineral oil and glycerol;
the antioxidant is one or a mixture of two or more of radix Rhodiolae, semen Ginkgo, ginsenoside, superoxide dismutase and collagen;
the soothing agent is one or a mixture of spring water and chamomile;
the auxiliary emulsifier is one or a mixture of two or more of ceteareth-25, glyceryl stearate and hydrolyzed jojoba esters;
the skin conditioner is one or a mixture of two or more of sodium hyaluronate, cassia tora extract, concha sclerostin powder, butterflybush flower leaf extract, mint leaf extract, wild chrysanthemum flower extract, crocus sativus extract, pearl powder, tocopherol acetate, hydroxyethyl cellulose and hydrolyzed procyanidin;
the solvent is water.
Wherein the aromatic is one or a mixture of astaxanthin and resveratrol;
the PH regulator is chloro-n-glycofen;
the preservative is one or a mixture of two of methyl hydroxybenzoate and hydroxyphenylpropanol;
the chelating agent is disodium EDTA.
A preparation method of eye cream for relieving asthenopia comprises the following steps:
s1, mixing the aromatic, the pH regulator, the preservative and the chelating agent, heating to 76-80 ℃, stirring at 20-25rpm for 40-45 minutes, and then keeping the temperature for 0,8-1 hour to obtain an oil phase;
s2, mixing the moisturizing agent, the emollient, the antioxidant, the soothing agent, the co-emulsifier, the skin conditioner and the solvent, heating to 78-82 ℃, and stirring at 40-55rpm for 60 minutes to obtain a water phase;
s3, adding an oil phase into the just prepared water phase, and stirring the mixture of the water phase and the oil phase at the speed of 1000-1250rpm for 20-24 minutes;
s4, mixing and stirring, and cooling the mixture to 28-30 ℃ to obtain the eye cream.
The invention has the technical effects and advantages that: the eye cream for relieving asthenopia and its preparation method are added with radix Rhodiolae, semen Ginkgo, ginsenoside, superoxide dismutase and collagen, effectively supplement collagen, reduce fishtail line, and make user skin have long-term antioxidant effect, and delay skin aging; the spring water and the chamomile are added to play a role in relieving the skin, so that the eye cream does not have acerbity discomfort in the process of wiping and blending the eye cream into the skin of a user, and the use experience is improved; the added cyclopentadimethylsiloxane, mineral oil and glycerin supplement oil which is easy to lose on the surface of the skin of a user, so that the skin of the user has more exquisite and glossy appearance; the hydroxyethyl cellulose and the hydrolyzed procyanidin can make the periphery of eyes of a user cool, thereby relieving asthenopia caused by long-time use of eyes.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The invention provides eye cream for relieving asthenopia, which comprises the following components in parts by weight: 1.0 part of humectant, 8.4 parts of emollient, 3.6 parts of antioxidant, 1.5 parts of soothing agent, 1.2 parts of co-emulsifier, 6.0 parts of skin conditioner, 1.0 part of aromatic, 0.2 part of pH regulator, 1.5 parts of preservative, 0.45 part of chelating agent and 75.15 parts of water.
Wherein the humectant is one or a mixture of two or more of propylene glycol, cetearyl alcohol and betaine;
the emollient is one or a mixture of two or more of cyclopentadimethylsiloxane, mineral oil and glycerol;
the antioxidant is one or a mixture of two or more of radix Rhodiolae, semen Ginkgo, ginsenoside, superoxide dismutase and collagen;
the soothing agent is one or a mixture of spring water and chamomile;
the auxiliary emulsifier is one or a mixture of two or more of ceteareth-25, glyceryl stearate and hydrolyzed jojoba esters;
the skin conditioner is one or a mixture of two or more of sodium hyaluronate, cassia tora extract, concha sclerostin powder, butterflybush flower leaf extract, mint leaf extract, wild chrysanthemum flower extract, crocus sativus extract, pearl powder, tocopherol acetate, hydroxyethyl cellulose and hydrolyzed procyanidin;
the solvent is water.
Wherein the aromatic is one or a mixture of astaxanthin and resveratrol;
the PH regulator is chloro-n-glycofen;
the preservative is one or a mixture of two of methyl hydroxybenzoate and hydroxyphenylpropanol;
the chelating agent is disodium EDTA.
A preparation method of eye cream for relieving asthenopia comprises the following steps:
s1, mixing the aromatic, the pH regulator, the preservative and the chelating agent, heating to 76-80 ℃, stirring at 20-25rpm for 40-45 minutes, and then keeping the temperature for 0,8-1 hour to obtain an oil phase;
s2, mixing the moisturizing agent, the emollient, the antioxidant, the soothing agent, the co-emulsifier, the skin conditioner and the solvent, heating to 78-82 ℃, and stirring at 40-55rpm for 60 minutes to obtain a water phase;
s3, adding an oil phase into the just prepared water phase, and stirring the mixture of the water phase and the oil phase at the speed of 1000-1250rpm for 20-24 minutes;
s4, mixing and stirring, and cooling the mixture to 28-30 ℃ to obtain the eye cream.
The following are specific experiments of the eye cream for relieving asthenopia:
selecting 180 women of 18-25 years old, continuously using the eye cream for relieving asthenopia for two months, and using 2-5ml at 7 am, 1 am and 9 pm each day, wherein the using method comprises smearing and wiping the eye cream on the periphery of eye circles; after waiting two months, the results were found to be as follows:
the number of the crow's feet of the skin around the eye ring is 82%, the number of the crow's feet of the skin around the eye ring is 14%, and the number of the crow's feet of the skin is 4%, so that the eye cream for relieving asthenopia can effectively reduce the crow's feet and slow down the aging of the skin.
Example 2
The invention provides eye cream for relieving asthenopia, which comprises the following components in parts by weight: 0.8 part of humectant, 9.4 parts of emollient, 3.2 parts of antioxidant, 1.7 parts of soothing agent, 1.1 parts of co-emulsifier, 7.0 parts of skin conditioner, 1.4 parts of aromatic, 0.2 part of pH regulator, 1.45 parts of preservative, 0.4 part of chelating agent and 73.35 parts of water.
Wherein the humectant is one or a mixture of two or more of propylene glycol, cetearyl alcohol and betaine;
the emollient is one or a mixture of two or more of cyclopentadimethylsiloxane, mineral oil and glycerol;
the antioxidant is one or a mixture of two or more of radix Rhodiolae, semen Ginkgo, ginsenoside, superoxide dismutase and collagen;
the soothing agent is one or a mixture of spring water and chamomile;
the auxiliary emulsifier is one or a mixture of two or more of ceteareth-25, glyceryl stearate and hydrolyzed jojoba esters;
the skin conditioner is one or a mixture of two or more of sodium hyaluronate, cassia tora extract, concha sclerostin powder, butterflybush flower leaf extract, mint leaf extract, wild chrysanthemum flower extract, crocus sativus extract, pearl powder, tocopherol acetate, hydroxyethyl cellulose and hydrolyzed procyanidin;
the solvent is water.
Wherein the aromatic is one or a mixture of astaxanthin and resveratrol;
the PH regulator is chloro-n-glycofen;
the preservative is one or a mixture of two of methyl hydroxybenzoate and hydroxyphenylpropanol;
the chelating agent is disodium EDTA.
A preparation method of eye cream for relieving asthenopia comprises the following steps:
s1, mixing the aromatic, the pH regulator, the preservative and the chelating agent, heating to 76-80 ℃, stirring at 20-25rpm for 40-45 minutes, and then keeping the temperature for 0,8-1 hour to obtain an oil phase;
s2, mixing the moisturizing agent, the emollient, the antioxidant, the soothing agent, the co-emulsifier, the skin conditioner and the solvent, heating to 78-82 ℃, and stirring at 40-55rpm for 60 minutes to obtain a water phase;
s3, adding an oil phase into the just prepared water phase, and stirring the mixture of the water phase and the oil phase at the speed of 1000-1250rpm for 20-24 minutes;
s4, mixing and stirring, and cooling the mixture to 28-30 ℃ to obtain the eye cream.
The following are specific experiments of the eye cream for relieving asthenopia:
selecting 180 women of 18-25 years old, continuously using the eye cream for relieving asthenopia for two months, and using 2-5ml at 7 am, 1 am and 9 pm each day, wherein the using method comprises smearing and wiping the eye cream on the periphery of eye circles; after waiting two months, the results were found to be as follows:
the number of the crow's feet of the skin around the eyeballs is 79%, the number of the crow's feet of the skin around the eyeballs is 15%, and the number of the crow's feet of the skin around the eyeballs is 6%, so that the eyeballs for relieving the asthenopia can effectively reduce the crow's feet and slow down the aging of the skin.
Example 3
The invention provides eye cream for relieving asthenopia, which comprises the following components in parts by weight: 0.2 part of humectant, 11.4 parts of emollient, 3.8 parts of antioxidant, 1.2 parts of soothing agent, 1.05 parts of co-emulsifier, 8.0 parts of skin conditioner, 1.0 part of aromatic, 0.2 part of pH regulator, 1.5 parts of preservative, 0.5 part of chelating agent and 71.15 parts of water.
Wherein the humectant is one or a mixture of two or more of propylene glycol, cetearyl alcohol and betaine;
the emollient is one or a mixture of two or more of cyclopentadimethylsiloxane, mineral oil and glycerol;
the antioxidant is one or a mixture of two or more of radix Rhodiolae, semen Ginkgo, ginsenoside, superoxide dismutase and collagen;
the soothing agent is one or a mixture of spring water and chamomile;
the auxiliary emulsifier is one or a mixture of two or more of ceteareth-25, glyceryl stearate and hydrolyzed jojoba esters;
the skin conditioner is one or a mixture of two or more of sodium hyaluronate, cassia tora extract, concha sclerostin powder, butterflybush flower leaf extract, mint leaf extract, wild chrysanthemum flower extract, crocus sativus extract, pearl powder, tocopherol acetate, hydroxyethyl cellulose and hydrolyzed procyanidin;
the solvent is water.
Wherein the aromatic is one or a mixture of astaxanthin and resveratrol;
the PH regulator is chloro-n-glycofen;
the preservative is one or a mixture of two of methyl hydroxybenzoate and hydroxyphenylpropanol;
the chelating agent is disodium EDTA.
A preparation method of eye cream for relieving asthenopia comprises the following steps:
s1, mixing the aromatic, the pH regulator, the preservative and the chelating agent, heating to 76-80 ℃, stirring at 20-25rpm for 40-45 minutes, and then keeping the temperature for 0,8-1 hour to obtain an oil phase;
s2, mixing the moisturizing agent, the emollient, the antioxidant, the soothing agent, the co-emulsifier, the skin conditioner and the solvent, heating to 78-82 ℃, and stirring at 40-55rpm for 60 minutes to obtain a water phase;
s3, adding an oil phase into the just prepared water phase, and stirring the mixture of the water phase and the oil phase at the speed of 1000-1250rpm for 20-24 minutes;
s4, mixing and stirring, and cooling the mixture to 28-30 ℃ to obtain the eye cream.
The following are specific experiments of the eye cream for relieving asthenopia:
selecting 180 women of 18-25 years old, continuously using the eye cream for relieving asthenopia for two months, and using 2-5ml at 7 am, 1 am and 9 pm each day, wherein the using method comprises smearing and wiping the eye cream on the periphery of eye circles; after waiting two months, the results were found to be as follows:
the crow's feet of the skin around the eyeshot are reduced by 78%, the crow's feet are unchanged by 16%, and the crow's feet are increased by 6%, so that the eyeshot can effectively reduce the crow's feet and slow down the aging of the skin.
In conclusion, the eye cream for relieving the asthenopia has good functions of removing fishtail wrinkles, enabling skin to be young and having stronger anti-aging capability.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments or portions thereof without departing from the spirit and scope of the invention.
Claims (5)
1. An eye cream for relieving asthenopia, which is characterized in that: the eye cream comprises the following components in parts by weight: 0.17-1.2 parts of humectant, 7.4-12.4 parts of emollient, 3.06-3.8 parts of antioxidant, 1.0-1.9 parts of soothing agent, 1.03-1.24 parts of co-emulsifier, 5.55-8.05 parts of skin conditioner, 0.68-1.6 parts of aromatic, 0.2 parts of pH regulator, 1.4-1.6 parts of preservative, 0.4-0.5 part of chelating agent and the balance of solvent.
2. The eye cream for relieving asthenopia according to claim 1, wherein: 1.0 part of humectant, 8.4 parts of emollient, 3.6 parts of antioxidant, 1.5 parts of soothing agent, 1.2 parts of co-emulsifier, 6.0 parts of skin conditioner, 1.0 part of aromatic, 0.2 part of pH regulator, 1.5 parts of preservative, 0.45 part of chelating agent and 75.15 parts of water.
3. The eye cream for relieving asthenopia according to claim 2, wherein: the humectant is any one or a mixture of two or more of propylene glycol, cetostearyl alcohol and betaine;
the emollient is one or a mixture of two or more of cyclopentadimethylsiloxane, mineral oil and glycerol;
the antioxidant is one or a mixture of two or more of radix Rhodiolae, semen Ginkgo, ginsenoside, superoxide dismutase and collagen;
the soothing agent is one or a mixture of spring water and chamomile;
the auxiliary emulsifier is one or a mixture of two or more of ceteareth-25, glyceryl stearate and hydrolyzed jojoba esters;
the skin conditioner is one or a mixture of two or more of sodium hyaluronate, cassia tora extract, concha sclerostin powder, butterflybush flower leaf extract, mint leaf extract, wild chrysanthemum flower extract, crocus sativus extract, pearl powder, tocopherol acetate, hydroxyethyl cellulose and hydrolyzed procyanidin;
the solvent is water.
4. The eye cream for relieving asthenopia according to claim 3, wherein: the aromatic is one or a mixture of astaxanthin and resveratrol;
the PH regulator is chloro-n-glycofen;
the preservative is one or a mixture of two of methyl hydroxybenzoate and hydroxyphenylpropanol;
the chelating agent is disodium EDTA.
5. The preparation method of the eye cream for relieving the asthenopia according to any one of claims 1 to 4, which comprises the following steps:
s1, mixing the aromatic, the pH regulator, the preservative and the chelating agent, heating to 76-80 ℃, stirring at 20-25rpm for 40-45 minutes, and then keeping the temperature for 0,8-1 hour to obtain an oil phase;
s2, mixing the moisturizing agent, the emollient, the antioxidant, the soothing agent, the co-emulsifier, the skin conditioner and the solvent, heating to 78-82 ℃, and stirring at 40-55rpm for 60 minutes to obtain a water phase;
s3, adding an oil phase into the just prepared water phase, and stirring the mixture of the water phase and the oil phase at the speed of 1000-1250rpm for 20-24 minutes;
s4, mixing and stirring, and cooling the mixture to 28-30 ℃ to obtain the eye cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011148300.6A CN112336660A (en) | 2020-10-23 | 2020-10-23 | Eye cream for relieving asthenopia and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011148300.6A CN112336660A (en) | 2020-10-23 | 2020-10-23 | Eye cream for relieving asthenopia and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112336660A true CN112336660A (en) | 2021-02-09 |
Family
ID=74360059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011148300.6A Pending CN112336660A (en) | 2020-10-23 | 2020-10-23 | Eye cream for relieving asthenopia and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112336660A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2886723A1 (en) * | 2021-07-23 | 2021-12-20 | Fundacion Para El Fomento De La Investig Sanitaria Y Biomedica De La Comunidad Valenciana Fisabio | COMPOSITION BASED ON THE ANTIOXIDANT ACTIVITY OF THE ENZYME SUPEROXIDE DISMUTASE AND ITS APPLICATION IN EYE DISEASES (Machine-translation by Google Translate, not legally binding) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106726760A (en) * | 2016-12-24 | 2017-05-31 | 严志海 | A kind of eye cream and preparation method thereof |
| CN111249187A (en) * | 2018-12-03 | 2020-06-09 | 西安博鸿生物技术有限公司 | Wrinkle-removing eye cream and preparation method thereof |
-
2020
- 2020-10-23 CN CN202011148300.6A patent/CN112336660A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106726760A (en) * | 2016-12-24 | 2017-05-31 | 严志海 | A kind of eye cream and preparation method thereof |
| CN111249187A (en) * | 2018-12-03 | 2020-06-09 | 西安博鸿生物技术有限公司 | Wrinkle-removing eye cream and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2886723A1 (en) * | 2021-07-23 | 2021-12-20 | Fundacion Para El Fomento De La Investig Sanitaria Y Biomedica De La Comunidad Valenciana Fisabio | COMPOSITION BASED ON THE ANTIOXIDANT ACTIVITY OF THE ENZYME SUPEROXIDE DISMUTASE AND ITS APPLICATION IN EYE DISEASES (Machine-translation by Google Translate, not legally binding) |
| WO2023002088A1 (en) * | 2021-07-23 | 2023-01-26 | Fundación para el Fomento de la investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO) | Composition based on the antioxidant activity of the enzyme superoxide dismutase and application thereof in eye diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106580798B (en) | A kind of all about eyes and preparation method | |
| CN105411931A (en) | Whitening cosmetic composition | |
| CN110638709A (en) | Anti-blue-light multi-effect repair eye cream and preparation method thereof | |
| CN106420488A (en) | Regenerating nourishing anti-wrinkle eye cream | |
| CN112641694B (en) | Whitening essence milk and preparation method thereof | |
| CN107375145B (en) | Cosmetic matrix, preparation method and application thereof, eye cream and preparation method thereof | |
| CN105434209A (en) | Composition for beautifying, removing wrinkles, tightening and shaping and preparation method thereof | |
| CN112603870A (en) | Multi-effect essence cream and preparation method thereof | |
| CN109528543A (en) | One kind repairing sensitive skin lotion and preparation method thereof based on private gene customization | |
| CN112336660A (en) | Eye cream for relieving asthenopia and preparation method thereof | |
| CN103494719A (en) | Anti-aging cream and preparation method thereof | |
| CN105326696A (en) | Natural plant antioxidant essence milk and preparation method thereof | |
| CN114504515A (en) | Water-based powdery eyebrow powder and preparation method thereof | |
| CN102058513B (en) | Chinese herbal medicine crude solution and cosmetic containing same | |
| CN110101591A (en) | A kind of long-acting moisture-keeping composition and its preparation method and application | |
| CN111434332A (en) | Nourishing and repairing emulsion and preparation method thereof | |
| CN108619047A (en) | A kind of cosmetic formulations of anti-aging and preparation method thereof | |
| CN112190518A (en) | Whitening and moisturizing mask and preparation method thereof | |
| CN111632008A (en) | CBD hemp essence emulsion and preparation method thereof | |
| CN110897905A (en) | Ginseng eye nutrition essence and preparation method thereof | |
| CN113577008B (en) | Toning lotion with moisturizing and antioxidant effects and skin activating effects and preparation method thereof | |
| CN114601765A (en) | Camellia flower water emulsion with moisturizing and oxidation resisting functions | |
| CN111184644B (en) | Application of artemisinin as antiallergic component in cosmetics | |
| CN107468605A (en) | A kind of refrigerant talcum powder of Asian puccoon green tea | |
| CN114159327A (en) | Mild hair-care type infant shampoo and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210209 |
|
| RJ01 | Rejection of invention patent application after publication |